Durham, NC – Durham Regional Hospital has received the American College of Cardiology Foundation’s NCDR ACTION Registry–GWTG Gold Performance Achievement Award for 2011 – one of only 167 hospitals nationwide to do so. The award recognizes Durham Regional’s commitment and success in implementing a higher standard of care for heart attack patients, and signifies that Durham Regional has reached an aggressive goal of treating these patients to standard levels of care as outlined by the American College of Cardiology/American Heart Association clinical guidelines and recommendations. This is the second straight year Durham Regional has achieved this award.
To receive the ACTION Registry–GWTG Gold Performance Achievement Award, Durham Regional consistently followed the treatment guidelines in ACTION Registry–GWTG for 8 consecutive quarters and met a performance standard of 85 percent for specific performance measures. Guidelines monitor drug safety and the overall quality of care provided to ST-elevation myocardial infarction (STEMI) and non- ST- elevation myocardial infarction patients (NSTEMI).
“This award reflects our commitment to excellent cardiac care throughout a patient’s entire experience,” says Michael Komada, MD, FACC, interventional cardiologist at Durham Regional. “Heart attack patients receive seamless, streamlined care, from first contact to discharge, resulting in better outcomes for our patients.”
ACTION Registry–GWTG is a partnership between the American College of Cardiology Foundation and the American Heart Association with partnering support from the American College of Emergency Physicians, Society of Chest Pain Centers and the Society of Hospital Medicine. ACTION Registry-GWTG empowers health care provider teams to consistently treat heart attack patients according to the most current, science-based guidelines and establishes a national standard for understanding and improving the quality, safety and outcomes of care provided for patients with coronary artery disease, specifically high-risk STEMI and NSTEMI patients.